Liu F, Pinz K, Ma Y, et al. First-in-human CLL1-DC33 compound CAR T cells as a two-pronged approach for the treatment of refractory acute myeloid leukemia. EHA 2018; abstract S149.
FDA keurt bosutinib goed voor behandeling kinderen met CML
dec 2023 | Leukemie